Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma
Kerala Journal of Ophthalmology · 2016
DOI: 10.4103/0976-6677.193884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kerala Journal of Ophthalmology, 2016. Verfasst von Prajina Rahul und 4 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Hepatitis C virus (HCV) is a blood-borne RNA virus that causes hepatitis C, chronic liver disease, and hepatocellular carcinoma. Patients with HCV infection are now treated with a combination of interferon alpha, which has antiviral and immunomodulatory properties, and ribavirin, an antiviral medication included in the family of nucleoside analogs. Recently, a long acting form of interferon alpha (pegylated interferon) has been developed, which has a more sustained antiviral response. One of the ocular side effects of interferon alpha is proliferative retinopathy related to ischemia. Interferon-associated retinopathy is usually mild and resolves completely, but occasionally, it can become severe.
Zitieren
APA
Rahul, P., Venugopal, M., Sija, S., Dhanya, R., & John, E. (2016). Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma. Kerala Journal of Ophthalmology. https://doi.org/10.4103/0976-6677.193884
Vancouver
Rahul P, Venugopal M, Sija S, Dhanya R, John E. Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma. Kerala Journal of Ophthalmology. 2016. doi:10.4103/0976-6677.193884
BibTeX
@article{Rahul2016,
author = {Rahul, Prajina and Venugopal, Manoj and Sija, S and Dhanya, RS and John, Elizabeth},
title = {Proliferative retinopathy in a diabetic on interferon therapy: A diagnostic dilemma},
journal = {Kerala Journal of Ophthalmology},
year = {2016},
doi = {10.4103/0976-6677.193884}
}
EUVIMED